IDO‐1 can activate Tregs and consume tumor‐infiltrating CTLs by metabolizing Trp into Kyn, while PD‐L1, which is overexpressed on tumor cells, can trigger CTL depletion through interaction with PD‐1 expressed on T cells. The gene discussed is PDCD1; the disease is neoplasm.